HTR1A and depressive disorder: Finally, Cannabidiol (Table 1), one of the main compounds in cannabis, has therapeutic potential against anxiety, depression, psychosis, epilepsy, and neuroprotection through the regulation of 5-HT1A (García-Gutiérrez et al., 2020).